Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigation of potential drug-drug interactions between faldaprevir and immunosuppressants (Cyclosporine and Tacrolimus) in healthy male and female subjects (Open-label, Fixed-sequence Trial)

Trial Profile

Investigation of potential drug-drug interactions between faldaprevir and immunosuppressants (Cyclosporine and Tacrolimus) in healthy male and female subjects (Open-label, Fixed-sequence Trial)

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jul 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Faldaprevir (Primary) ; Ciclosporin; Tacrolimus
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 19 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 30 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Feb 2014 According to the ClinicalTrials.gov record, Faldaprevir Alone and Faldaprevir in Combination With Deleobuvir arm groups were removed; number of patient changed from 64 to 32; and the primary end point C12ss was replaced with AUCt,ss.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top